Literature DB >> 23572491

Impact of residual chronic total occlusion of right coronary artery on the long-term outcome in patients treated for unprotected left main disease: the Milan and New-Tokyo registry.

Kensuke Takagi1, Alfonso Ielasi, Alaide Chieffo, Sandeep Basavarajaiah, Azeem Latib, Matteo Montorfano, Mauro Carlino, Hiroyuki Mizuno, Tasuku Hasegawa, Cosmo Godino, Filippo Figini, Joanne Shannon, Ahmed Rezq, Santo Ferrarello, Chiara Bernelli, Toru Naganuma, Yusuke Fujino, Sunao Nakamura, Antonio Colombo.   

Abstract

BACKGROUND: The presence of chronic total occlusion of the right coronary artery (CTO-RCA) in patients undergoing percutaneous interventions for unprotected left main (ULM) disease may affect the prognosis. In this study, we evaluated the immediate results and follow-up of patients with ULM-percutaneous interventions and with or without associated CTO-RCA. METHODS AND
RESULTS: Between March 2002 and December 2008, a total of 568 consecutive patients with ULM stenosis treated with drug-eluting stent were included in this analysis. The mean EuroScore and SYNTAX scores were 4.05±2.62 and 28.12±10.82, respectively. Of these, 522 had ULM lesions without residual CTO-RCA (493 ULM without CTO-RCA+29 ULM with treated CTO-RCA), and 46 patients had residual CTO-RCA. At 1466 days (interquartile range, 1150-1917) follow-up, the cardiac-death occurred in 41 patients (7.2%). Cardiac-death was more frequently observed in patients with ULM and residual CTO-RCA as compared with those without residual CTO-RCA (adjusted hazard ratios, 2.163 [95% confidence interval, 1.018-4.597]; P=0.045). However, target lesion revascularization occurred less frequently in patients with residual CTO-RCA (adjusted hazard ratios, 0.321 [95% confidence interval, 0.13-0.794]; P=0.014), resulting in the similar major adverse cardiovascular events rates between the 2 groups. When we analyzed patients with concomitant ULM and CTO-RCA, cardiac-death was significantly higher in patients with residual as compared with treated CTO-RCA (log-rank P=0.01) despite no difference in baseline characteristics.
CONCLUSIONS: Cardiac-death occurred more frequently in patients with residual CTO-RCA as compared with those without residual CTO-RCA. These findings suggest that recanalization of CTO-RCA has significant impact on the long-term cardiac-mortality in patients undergoing ULM-percutaneous interventions probably by offering reserve coronary circulation, if in-stent restenosis were to occur in the treated left main.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23572491     DOI: 10.1161/CIRCINTERVENTIONS.112.000079

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  5 in total

1.  Chronic total occlusions - Current techniques and future directions.

Authors:  George Touma; David Ramsay; James Weaver
Journal:  Int J Cardiol Heart Vasc       Date:  2015-02-07

2.  Residual Right Coronary Artery Stenosis after Left Main Coronary Artery Intervention Increased the 30-Day Cardiovascular Death and 3-Year Right Coronary Artery Revascularization Rate.

Authors:  Chien-Ho Lee; Shaur-Zheng Chong; Shu-Kai Hsueh; Wen-Jung Chung; Cheng-I Cheng
Journal:  J Interv Cardiol       Date:  2020-06-14       Impact factor: 2.279

3.  Percutaneous coronary artery intervention in unprotected left main coronary artery disease: one-year outcome Egyptian registry.

Authors:  Rana Ayman; Sameh Mohamed Shaheen; Sameh Saleh Sabet; Yasser A Abdellatif
Journal:  Egypt Heart J       Date:  2022-09-06

4.  Meta-analysis of the effect of percutaneous coronary intervention on chronic total coronary occlusions.

Authors:  Ruogu Li; Shuansuo Yang; Lei Tang; Yiqing Yang; Hui Chen; Shaofeng Guan; Wenzheng Han; Hua Liu; Jinjie Dai; Qian Gan; Weiyi Fang; Xinkai Qu
Journal:  J Cardiothorac Surg       Date:  2014-02-28       Impact factor: 1.637

5.  Five-Year Outcomes of Successful Percutaneous Coronary Intervention with Drug-Eluting Stents versus Medical Therapy for Chronic Total Occlusions.

Authors:  Seung Woon Rha; Byoung Geol Choi; Man Jong Baek; Yang Gi Ryu; Hu Li; Se Yeon Choi; Jae Kyeong Byun; Ahmed Mashaly; Yoonjee Park; Won Young Jang; Woohyeun Kim; Jah Yeon Choi; Eun Jin Park; Jin Oh Na; Cheol Ung Choi; Hong Euy Lim; Eung Ju Kim; Chang Gyu Park; Hong Seog Seo; Dong Joo Oh
Journal:  Yonsei Med J       Date:  2018-07       Impact factor: 2.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.